Literature DB >> 19363636

Chagas disease is independently associated with brain atrophy.

Jamary Oliveira-Filho, Rodrigo M Vieira-de-Melo, Paulo S O Reis, Amanda M Lacerda, Iuri S Neville, Carolina Cincura, Daniela F Menezes, Leila C Viana, Pedro A P Jesus, Antonio A Lopes, Francisco J F B Reis, Karen L Furie.   

Abstract

Chagas disease (CD) remains a major cause of cardiomyopathy and stroke in developing countries. Brain involvement in CD has been attributed to left ventricular dysfunction, resulting in chronic brain ischemia due to hypoperfusion and/or embolic infarcts. However, cognitive impairment in CD may occur independently of cardiac disease. Therefore, we aimed to investigate head computed tomography (CT) findings in patients with Chagas disease cardiomyopathy (CDC) in comparison with other cardiomyopathies (OC). We studied 73 patients with CDC (n = 41) or OC (n = 32) matched for age and gender. These patients underwent head CT, rated by an investigator blinded to all clinical information. Head CT was rated for the presence of lacunar or territorial infarcts, as well as for measuring the total volumes of the brain, cerebellum and ventricles. Total brain volume was smaller in CDC as compared to OC patients (1,135 +/- 150 vs. 1,332 +/- 198 cm(3), P < 0.001). Cerebellar and ventricular volumes did not differ between the groups. The prevalence of brain infarcts did not differ significantly between the groups. Chagas disease was the only independent predictor of brain atrophy in the multivariable analysis (OR = 1.38; 95% CI = 1.06-1.79, P = 0.017). Chagas disease is associated with brain atrophy independent of structural cardiac disease related to cardiomyopathy. Brain atrophy, rather than multiple infarcts, may represent the main anatomical substrate of cognitive impairment in Chagas disease.

Entities:  

Mesh:

Year:  2009        PMID: 19363636     DOI: 10.1007/s00415-009-5105-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  [Anatomo-pathological study of the brain in idiopathic cardiomegaly].

Authors:  A C de Queiroz; E A Ramos
Journal:  Arq Neuropsiquiatr       Date:  1979-12       Impact factor: 1.420

2.  Evaluation of cytokines (MIG, IFN-gamma, TNF-alpha, IL-4, IL-5, and IL-10) during the different evolutive phases of chagasic esophagopathy.

Authors:  Eduardo Crema; Isabela de Oliveira Monteiro; Marília Gabriela Zanier Gomes; Alex Augusto Silva; Virmondes Rodrigues Júnior
Journal:  Clin Immunol       Date:  2006-02-28       Impact factor: 3.969

3.  Ischemic cerebral changes in the chronic chagasic cardiopathy.

Authors:  J E Pitella
Journal:  Arq Neuropsiquiatr       Date:  1984-06       Impact factor: 1.420

4.  Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy.

Authors:  B Chandrasekar; P C Melby; D A Troyer; G L Freeman
Journal:  Biochem Biophys Res Commun       Date:  1996-06-14       Impact factor: 3.575

5.  Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study.

Authors:  A L Jefferson; J M Massaro; P A Wolf; S Seshadri; R Au; R S Vasan; M G Larson; J B Meigs; J F Keaney; I Lipinska; S Kathiresan; E J Benjamin; C DeCarli
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

6.  American trypanosomiasis (Chagas' disease): an unrecognised cause of stroke.

Authors:  F J Carod-Artal; A P Vargas; M Melo; T A Horan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

Review 7.  Central nervous system involvement in Chagas' disease. An updating.

Authors:  J E Pittella
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1993 Mar-Apr       Impact factor: 1.846

  7 in total
  4 in total

Review 1.  Neurologic manifestations of Chagas disease.

Authors:  Marco Oliveira Py
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

2.  Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.

Authors:  Glaucia Vilar-Pereira; Leda Castaño Barrios; Andrea Alice da Silva; Angelica Martins Batista; Isabela Resende Pereira; Otacílio Cruz Moreira; Constança Britto; Hílton Antônio Mata Dos Santos; Joseli Lannes-Vieira
Journal:  PLoS One       Date:  2021-01-05       Impact factor: 3.240

3.  Clinical assessment, neuroimaging and immunomarkers in Chagas disease study (CLINICS): Rationale, study design and preliminary findings.

Authors:  Jamary Oliveira-Filho; Jesângeli de S Dias; Pedro A P Jesus; Nestor J S B Neto; Roque Aras; Francisco J F B Reis; Karen L Furie
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep

Review 4.  Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease.

Authors:  Rodolfo Kölliker-Frers; Lucas Udovin; Matilde Otero-Losada; Tamara Kobiec; María Inés Herrera; Jorge Palacios; Gabriela Razzitte; Francisco Capani
Journal:  Mediators Inflamm       Date:  2021-05-31       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.